Brief: Standard BioTools Q3 net income USD -21 million
07/11/2023 21:46
Nov 7 (Reuters) - Standard BioTools Q3 basic EPS USD -0.27. * Q3 pretax profit USD -20.947 million * Q3 adjusted gross margin 57% * Q3 adjusted EBITDA USD -10.1 million * Q3 operating income USD -21.2 million * Q3 net income USD -21 million * Q3 gross margin 44%
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07